Log in
TSE:CRON

Cronos Group Inc. (CRON.TO) Stock Forecast, Price & News

C$10.84
+0.71 (+7.01 %)
(As of 11/27/2020 04:00 PM ET)
Add
Compare
Today's Range
C$9.92
Now: C$10.84
C$11.20
50-Day Range
C$7.06
MA: C$8.36
C$10.41
52-Week Range
C$5.82
Now: C$10.84
C$11.74
Volume2.22 million shs
Average Volume1.02 million shs
Market CapitalizationC$3.86 billion
P/E Ratio37.77
Dividend YieldN/A
BetaN/A
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.
Read More
Cronos Group Inc. (CRON.TO) logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.64 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone416-504-0004
Employees631

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$36.98 million
Cash FlowC$3.84 per share
Book ValueC$4.97 per share

Profitability

Miscellaneous

Market CapC$3.86 billion
Next Earnings DateN/A
OptionableOptionable
C$10.84
+0.71 (+7.01 %)
(As of 11/27/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cronos Group Inc. (CRON.TO) (TSE:CRON) Frequently Asked Questions

How has Cronos Group Inc. (CRON.TO)'s stock been impacted by COVID-19 (Coronavirus)?

Cronos Group Inc. (CRON.TO)'s stock was trading at C$7.45 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CRON stock has increased by 45.5% and is now trading at C$10.84.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Cronos Group Inc. (CRON.TO)?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group Inc. (CRON.TO) in the last year. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Cronos Group Inc. (CRON.TO)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Cronos Group Inc. (CRON.TO)?

Wall Street analysts have given Cronos Group Inc. (CRON.TO) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cronos Group Inc. (CRON.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for CRON?

5 Wall Street analysts have issued 12 month target prices for Cronos Group Inc. (CRON.TO)'s stock. Their forecasts range from C$5.00 to C$11.00. On average, they expect Cronos Group Inc. (CRON.TO)'s share price to reach C$8.07 in the next twelve months. This suggests that the stock has a possible downside of 25.5%.
View analysts' price targets for Cronos Group Inc. (CRON.TO)
.

Who are some of Cronos Group Inc. (CRON.TO)'s key competitors?

What other stocks do shareholders of Cronos Group Inc. (CRON.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group Inc. (CRON.TO) investors own include Aurora Cannabis Inc. (ACB.TO) (ACB), Canopy Growth (CGC), Aurora Cannabis (ACB), Canopy Growth (WEED), NVIDIA (NVDA), Aphria Inc. (APHA.TO) (APHA), Advanced Micro Devices (AMD), Netflix (NFLX), The Walt Disney (DIS) and Intel (INTC).

Who are Cronos Group Inc. (CRON.TO)'s key executives?

Cronos Group Inc. (CRON.TO)'s management team includes the following people:
  • Mr. Michael Ryan Gorenstein, Exec. Chairman (Age 33, Pay $333.57k)
  • Mr. Jerry Filomena Barbato, Chief Financial Officer (Age 44, Pay $299.63k)
  • Ms. Xiuming Shum, Exec. VP of Legal and Regulatory Affairs & Corp. Sec. (Age 34, Pay $190.18k)
  • Mr. Kurt Thomas Schmidt B.Sc., M.B.A., Pres & CEO (Age 63)
  • Mr. Shayne J. Laidlaw, Director of Investor Relations & Strategy
  • Mr. Eric Klein, Head of Marketing
  • Ms. Shannon Buggy, Sr. VP & Global Head of People
  • Ms. Anna Shlimak, Sr. VP of Corp. Affairs (Age 34)
  • Dr. Todd K. Abraham, Chief Innovation Officer (Age 65)
  • Puneet Mathur, VP & Controller

What is Cronos Group Inc. (CRON.TO)'s stock symbol?

Cronos Group Inc. (CRON.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON."

How do I buy shares of Cronos Group Inc. (CRON.TO)?

Shares of CRON and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Cronos Group Inc. (CRON.TO)'s stock price today?

One share of CRON stock can currently be purchased for approximately C$10.84.

How big of a company is Cronos Group Inc. (CRON.TO)?

Cronos Group Inc. (CRON.TO) has a market capitalization of C$3.86 billion and generates C$36.98 million in revenue each year. Cronos Group Inc. (CRON.TO) employs 631 workers across the globe.

What is Cronos Group Inc. (CRON.TO)'s official website?

The official website for Cronos Group Inc. (CRON.TO) is www.thecronosgroup.com.

How can I contact Cronos Group Inc. (CRON.TO)?

The company can be reached via phone at 416-504-0004.

This page was last updated on 11/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.